Professor Thomson has spent most of his professional life at City, University of London, where he lectured in Clinical Optometry and Visual Perception before becoming Head of Department.
In the late 90s he recognised the potential of emerging computer and display technology for vision assessment and screening, and started developing software to exploit the new technology. The first programme was launched in 1992 and from these humble beginnings, his software is now used in thousands of clinics and schools worldwide. He started developing software for vision screening in schools over ten years ago and the current version reflects his years of experience in this field. He continues to lead the product development in the company while lecturing widely in the UK and overseas.
In November 2016, Professor Thomson was elected a Life Fellow of The College of Optometrists for his outstanding contribution to the profession.
Sebastian is a Consultant in Paediatric Audiovestibular Medicine at UCLH (Royal National Throat Nose & Ear Hospital and the Royal Free London NHS Foundation Trust).
He has an MSc in Audiovestibular Medicine and is a Fellow of the Royal College of Physicians as well as the Royal College of Paediatrics & Child Health. He has a dual accreditation as a specialist in paediatrics and in audiovestibular medicine, the discipline specialised in hearing and balance problems. Sebastian was chair of the paediatric section of the British Society of Audiology and was a member of its council and a trustee of the society. Sebastian was a member of and held various positions in the British Association of Audiovestibular Physicians. He is also chair of the joint quality committee of the clinical commissioning groups in Northamptonshire, NHS Corby CCG and NHS Nene CCG. He also is a governing body member of NHS Corby CCG.
Michael was CEO of the Map of Medicine (UCL and The Royal Free Hospital) - a clinical knowledge application in widespread use by doctors in the UK. He is Chairman of Virtual Tutor NurseEXCEL (clinical governance software for Hospitals; City, University of London). Previous experience includes managing and investing in healthcare, global education services and information software businesses. Michael has an MSc and Sloan Fellowship from London Business School. Chaired the Commercial Board and is a member of the Enterprise Board at the University of Liverpool.
Marta brings operational and healthcare management experience to the team. Following her MA in English and Scandinavian Studies from ELTE University Budapest, Marta moved to the UK where she went on to City, University of London (now the Cass Business School) to complete her MBA. She started her career in supply chain management for GE where she participated in the Change Acceleration Programme and was trained as a Six Sigma Black Belt. In her projects covered Eastern and Western Europe and Africa. After leaving GE Marta set up her own supply chain consultancy for European clients later using her operational skills in healthcare related industries. Since 2004 Marta has had a number of senior healthcare operational and programme management roles both in the NHS the private sector. For 4 years she was a managing director of a private eye care business in central London.
Tim Cooke (Non-Executive Chairman) has worked in senior levels in media, software, and IT services companies throughout his working life. Tim has a Chemistry MA and DPhil from Oxford University and an MTech from Brunel University. He was an early employee with Logica, where he held numerous senior management positions in the UK and overseas. He was later Managing Director of Oxford Molecular Group plc and floated this software based drug design and genomics company. He has also floated Intelligent Environments plc, the London stock market’s first internet company. He was a founder director of Anson Medical Plc, the medical device company. Tim holds a portfolio of Non-Executive Chairmanships and Directorships and is currently Chairman of Six to Start Ltd and Clarinet Ltd. He is also Venture Partner to NESTA, the National Endowment for Science, Technology and the Arts, a leading investor in early stage technology companies.